JDMAX
Price
$141.54
Change
+$1.15 (+0.82%)
Updated
Oct 8 closing price
Net Assets
23.75B
PSKCX
Price
$44.96
Change
+$0.40 (+0.90%)
Updated
Oct 8 closing price
Net Assets
923.46M
Interact to see
Advertisement

JDMAX vs PSKCX

Header iconJDMAX vs PSKCX Comparison
Open Charts JDMAX vs PSKCXBanner chart's image
Janus Henderson Enterprise A
Price$141.54
Change+$1.15 (+0.82%)
VolumeN/A
Net Assets23.75B
Virtus KAR Mid-Cap Growth C
Price$44.96
Change+$0.40 (+0.90%)
VolumeN/A
Net Assets923.46M
JDMAX vs PSKCX Comparison Chart in %
View a ticker or compare two or three
VS
JDMAX vs. PSKCX commentary
Oct 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is JDMAX is a Buy and PSKCX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
JDMAX has more cash in the bank: 23.7B vs. PSKCX (923M). JDMAX pays higher dividends than PSKCX: JDMAX (0.75) vs PSKCX (0.00). JDMAX was incepted earlier than PSKCX: JDMAX (16 years) vs PSKCX (25 years). PSKCX (2.04) is less costly to investors than JDMAX (1.14). JDMAX is a more actively managed with annual turnover of: 15.00 vs. PSKCX (13.00). JDMAX (2500) and PSKCX (2500) have matching initial minimum investment requirements. PSKCX annual gain was more profitable for investors over the last year : 0.38 vs. JDMAX (-0.06). JDMAX return over 5 years is better than : -3.09 vs. PSKCX (-7.88).
JDMAXPSKCXJDMAX / PSKCX
Total Expense Ratio1.142.0456%
Annual Report Gross Expense Ratio1.142.0456%
Fund Existence16 years25 years-
Gain YTD5.0820.564901%
Front Load6%N/A-
Min. Initial Investment25002500100%
Min. Initial Investment IRAN/AN/A-
Net Assets23.7B923M2,568%
Annual Yield % from dividends0.750.00-
Returns for 1 year-0.060.38-17%
Returns for 3 years17.9232.3055%
Returns for 5 years-3.09-7.8839%
Returns for 10 years63.08152.0441%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
FATE1.510.12
+8.63%
Fate Therapeutics
ALUR2.170.10
+4.83%
Allurion Technologies
PHAT11.050.21
+1.94%
Phathom Pharmaceuticals
ERIC8.540.11
+1.30%
Ericsson
EEFT86.53-0.39
-0.45%
Euronet Worldwide